vs

Side-by-side financial comparison of Amarin Corp plc (AMRN) and Clipper Realty Inc. (CLPR). Click either name above to swap in a different company.

Amarin Corp plc is the larger business by last-quarter revenue ($45.1M vs $37.1M, roughly 1.2× Clipper Realty Inc.). Amarin Corp plc runs the higher net margin — -23.3% vs -30.4%, a 7.1% gap on every dollar of revenue. On growth, Amarin Corp plc posted the faster year-over-year revenue change (7.0% vs -2.6%). Over the past eight quarters, Clipper Realty Inc.'s revenue compounded faster (1.8% CAGR vs -18.3%).

Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa (AMR-101), a prescription grade omega-3 fatty acid.

Clipper Equity LLC is a partnership led by David Bistricer and Sam Levinson. The firm owns more than 60 buildings, with thousands of residential units, in New York and New Jersey. The partnership are known for their attempted purchase of the Starrett City housing complex in Brooklyn, New York, for $1.3 billion on February 8, 2007, in one of the largest real estate transactions in history. New York's Mayor Michael Bloomberg expressed concerns over the new landlord's history of building violati...

AMRN vs CLPR — Head-to-Head

Bigger by revenue
AMRN
AMRN
1.2× larger
AMRN
$45.1M
$37.1M
CLPR
Growing faster (revenue YoY)
AMRN
AMRN
+9.6% gap
AMRN
7.0%
-2.6%
CLPR
Higher net margin
AMRN
AMRN
7.1% more per $
AMRN
-23.3%
-30.4%
CLPR
Faster 2-yr revenue CAGR
CLPR
CLPR
Annualised
CLPR
1.8%
-18.3%
AMRN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
AMRN
AMRN
CLPR
CLPR
Revenue
$45.1M
$37.1M
Net Profit
$-10.5M
$-11.3M
Gross Margin
-5.2%
Operating Margin
35.5%
21.8%
Net Margin
-23.3%
-30.4%
Revenue YoY
7.0%
-2.6%
Net Profit YoY
33.0%
-938.6%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMRN
AMRN
CLPR
CLPR
Q1 26
$45.1M
Q4 25
$49.2M
$37.1M
Q3 25
$49.7M
$37.7M
Q2 25
$72.7M
$39.0M
Q1 25
$42.0M
$39.4M
Q4 24
$62.3M
$38.0M
Q3 24
$42.3M
$37.6M
Q2 24
$67.5M
$37.3M
Net Profit
AMRN
AMRN
CLPR
CLPR
Q1 26
$-10.5M
Q4 25
$-1.2M
$-11.3M
Q3 25
$-7.7M
$-4.6M
Q2 25
$-14.1M
$-1.4M
Q1 25
$-15.7M
$-35.1M
Q4 24
$-48.6M
$-1.1M
Q3 24
$-25.1M
$-1.1M
Q2 24
$1.5M
$-1.7M
Gross Margin
AMRN
AMRN
CLPR
CLPR
Q1 26
Q4 25
47.1%
-5.2%
Q3 25
44.7%
23.6%
Q2 25
69.2%
27.8%
Q1 25
59.8%
-34.5%
Q4 24
-15.4%
28.8%
Q3 24
38.5%
28.6%
Q2 24
63.4%
26.8%
Operating Margin
AMRN
AMRN
CLPR
CLPR
Q1 26
35.5%
Q4 25
-12.9%
21.8%
Q3 25
-22.4%
23.6%
Q2 25
-22.0%
27.7%
Q1 25
-39.9%
-59.9%
Q4 24
-84.3%
28.1%
Q3 24
-59.5%
28.6%
Q2 24
-0.8%
26.8%
Net Margin
AMRN
AMRN
CLPR
CLPR
Q1 26
-23.3%
Q4 25
-2.5%
-30.4%
Q3 25
-15.6%
-12.2%
Q2 25
-19.4%
-3.5%
Q1 25
-37.4%
-89.1%
Q4 24
-78.0%
-2.9%
Q3 24
-59.4%
-2.9%
Q2 24
2.3%
-4.7%
EPS (diluted)
AMRN
AMRN
CLPR
CLPR
Q1 26
Q4 25
$0.00
Q3 25
$-0.02
Q2 25
$-0.03
Q1 25
$-0.04
Q4 24
$-0.12
Q3 24
$-0.06
Q2 24
$0.00

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMRN
AMRN
CLPR
CLPR
Cash + ST InvestmentsLiquidity on hand
$307.8M
$30.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$-30.7M
Total Assets
$645.8M
$1.2B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMRN
AMRN
CLPR
CLPR
Q1 26
$307.8M
Q4 25
$302.6M
$30.8M
Q3 25
$286.6M
$26.1M
Q2 25
$298.7M
$32.0M
Q1 25
$281.8M
$21.3M
Q4 24
$294.2M
$19.9M
Q3 24
$305.7M
$18.6M
Q2 24
$306.7M
$20.3M
Total Debt
AMRN
AMRN
CLPR
CLPR
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
$1.3B
Q4 24
$1.3B
Q3 24
$1.3B
Q2 24
$1.2B
Stockholders' Equity
AMRN
AMRN
CLPR
CLPR
Q1 26
Q4 25
$459.3M
$-30.7M
Q3 25
$458.9M
$-25.0M
Q2 25
$464.9M
$-21.9M
Q1 25
$473.7M
$-20.1M
Q4 24
$486.2M
$-5.4M
Q3 24
$531.4M
$-3.6M
Q2 24
$551.9M
$-1.8M
Total Assets
AMRN
AMRN
CLPR
CLPR
Q1 26
$645.8M
Q4 25
$670.8M
$1.2B
Q3 25
$659.8M
$1.2B
Q2 25
$670.1M
$1.2B
Q1 25
$655.7M
$1.3B
Q4 24
$685.3M
$1.3B
Q3 24
$750.6M
$1.3B
Q2 24
$799.9M
$1.3B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMRN
AMRN
CLPR
CLPR
Operating Cash FlowLast quarter
$22.6M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMRN
AMRN
CLPR
CLPR
Q1 26
Q4 25
$15.3M
$22.6M
Q3 25
$-12.7M
$1.4M
Q2 25
$16.6M
$8.4M
Q1 25
$-12.5M
$6.7M
Q4 24
$-13.3M
$31.9M
Q3 24
$-2.4M
$6.3M
Q2 24
$-2.7M
$8.8M
Free Cash Flow
AMRN
AMRN
CLPR
CLPR
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
$-4.6M
Q4 24
$-37.9M
Q3 24
Q2 24
FCF Margin
AMRN
AMRN
CLPR
CLPR
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
-11.7%
Q4 24
-99.5%
Q3 24
Q2 24
Capex Intensity
AMRN
AMRN
CLPR
CLPR
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
28.6%
Q4 24
183.3%
Q3 24
Q2 24
Cash Conversion
AMRN
AMRN
CLPR
CLPR
Q1 26
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
-1.81×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMRN
AMRN

U.S$35.6M79%
Europe$4.9M11%
Rest-of-World (ROW)$2.8M6%
Licensing & Royalties$1.8M4%

CLPR
CLPR

Residential Segment$30.8M83%
Commercial Real Estate$6.2M17%

Related Comparisons